C21 Investments Inc. income statement CWLXF

Annual Quarterly

In fiscal 2026, which ended Mar 31, 2026, C21 Investments Inc. reported revenue of $32.6 million, up 8.3% from the year before. It recorded a net loss of $3.2 million. Operating income came to $2.3 million, an operating margin of 7.0%. Diluted earnings per share were -$0.03. Across the 8 fiscal years shown, revenue grew from $2.6 million in fiscal 2019 to $32.6 million in fiscal 2026, about 43.6% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Mar 31, 2026	FY 2025 Mar 31, 2025	FY 2024 Jan 31, 2024	FY 2023 Jan 31, 2023	FY 2022 Jan 31, 2022	FY 2022 Jan 31, 2021	FY 2020 Jan 31, 2020	FY 2019 Jan 31, 2019
Revenue	33 +8.3%	30 +6.5%	28 -2.1%	29 -12.4%	33	36	38 +1358.3%	3
Cost of revenue	19 +8.3%	18 +2.5%	17 +10.6%	15 +9.3%	14	19	26 +862.4%	3
Gross profit	14 +8.3%	13 +12.6%	11 -16.8%	13 -25.7%	19	18	13 +7096.3%	0
Selling, general and administrative	11 +0.4%	11 +16.5%	10 +2.5%	9 +4.3%	9	7	9 +47.0%	6
Other operating income (expense)	0 +224.5%	0 +223.1%	-0 +43.3%	-0	—	—	—	—
Operating income	2 +77.8%	1 -12.9%	1 -62.8%	4 -59.5%	10	—	—	—
Pretax income	1 +249.1%	0 +52.7%	0 -93.8%	4 -75.5%	17	-4	-29 -22.2%	-24
Income tax	5 +11.1%	4 +19.2%	3 +23.9%	3 -43.1%	5	—	—	—
Net income	-3 +18.3%	-4 -20.1%	-3 -1227.3%	0 -97.1%	10	—	—	—
Basic EPS	-0.03 +0.0%	-0.03 +0.0%	-0.03	0.00 -100.0%	0.08	—	—	—
Diluted EPS	-0.03 +0.0%	-0.03 +0.0%	-0.03	0.00 -100.0%	0.08	—	—	—
Weighted average shares, basic	118 -1.6%	120 -0.2%	120 +0.0%	120 +1.5%	118	—	—	—
Weighted average shares, diluted	118 -1.8%	121 -1.9%	123 +0.0%	123 +1.4%	121	—	—	—
Other measures
Depreciation and amortization	2 +4.3%	2 +21.1%	1 -23.6%	2 +1.4%	2	2	3 +487.3%	1
EBITDA	4 +35.8%	3 +3.7%	3 -50.3%	6 -49.9%	12	—	—	—
Interest coverage	12.17x	4.36x	41.81x	8.66x	2.48x	—	—	—
Margins
Gross margin	41.71%	41.70%	39.42%	46.39%	57.03%	49.95%	34.84%	7.06%
Operating margin	6.99%	4.26%	5.20%	13.69%	29.58%	—	—	—
Pretax margin	4.23%	1.31%	0.91%	14.51%	51.94%	-10.35%	-76.49%	-912.82%
Profit margin	-9.95%	-13.18%	-11.69%	1.01%	30.18%	—	—	—
EBITDA margin	12.44%	9.92%	10.19%	20.07%	35.09%	—	—	—
Effective tax rate	334.67%	1,051.26%	1,346.23%	67.04%	28.80%	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: CWLXF (OTC)
Fiscal year ends: March 31
Incorporated in: British Columbia, Canada
Headquarters: Vancouver
SEC filer status: Non-accelerated filer, Emerging growth company
SEC CIK: 831609
Former names: CURLEW LAKE RESOURCES INC (until Nov 29, 2012); CURLEW LAKE RESOURCES INC /FI (until Jan 3, 2007)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.